NEWS : CIMS Healthcare Excellence Awards 2017- Best Hospital Unit in Oncology & Individual Excellence in the field of Operations * Padmashree Dr. Ramakant Deshpande, Executive Chairman and Director of ACI, receiving an award for the Best Healthcare Entrepreneur at Global Awards for Excellence in Quality Management & Leadership * ACI DAYCARE-BORIVALI 4 Feb launching of centre by the hands of cabinet Minister Shree Vinod Tawde & sitting MP Shree Gopal Shetty * Click Here To Take Appointment!!! * We have Sucessfully performed 250 Robotic Surgery till date *
BLOG : Afatinib Superior to Erlotinin Liquid Biopsy gives 100% accuracy Head and Neck New Urinary Molecular Test

This month Xalkori (crizotinib) was approved by the U.S. Food and Drug Administration to treat advanced non-small-cell lung cancer (NSCLC) with tumors that have a rareROS1 gene mutation.

This is in addition to the drug’s approval (in 2011) for ALK positive advanced NSCLC.

At Asian Cancer Institute, we have ?renown international experts who have contributed to more than 10 global research publications to advances in treatment of Lung Cancer – some of these studies have even resulted in regulatory approval and are now recognized as landmark publications.

Dr. Purvish M. Parikh
Director of Precision Oncology
Medical Oncologist & Hematologist
Somaiya Ayurvihar – Asian Cancer Institute
Asian Cancer Institute